RAS encompasses multiple axes, among which the AngII signaling through its receptors AGTR1 and AGTR2 has been the subject of extensive research, where this axis is known to intersect with a variety of pathways implicated in tumorigenesis, highlighting its potential role in cancer biology. This evidence concerns the gene AGTR2 and cancer.